• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清白细胞介素和可溶性 ST2 在中医(TCM)辨证类风湿关节炎中的预后意义。

Prognostic Significance of Serum Interleukins and Soluble ST2 in Traditional Chinese Medicine (TCM) Syndrome-Differentiated Rheumatoid Arthritis.

机构信息

Department of Integrated Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland).

出版信息

Med Sci Monit. 2018 May 25;24:3472-3478. doi: 10.12659/MSM.907540.

DOI:10.12659/MSM.907540
PMID:29798971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5996845/
Abstract

BACKGROUND The aim of this study was to explore the possible correlations of serum interleukins and soluble ST2 (sST2) protein with clinical features and inflammatory cytokines in rheumatoid arthritis (RA) patients, as well as to assess ability of TCM (Traditional Chinese Medicine) syndromes to differentiate RA patients and evaluate prognosis. MATERIAL AND METHODS Thirty RA patients and 25 healthy individuals were enrolled. Syndrome activity was evaluated, and lab tests were performed. Serum levels of IL-10, IL-17, IL-33, and sST2 were assessed by ELISA. RESULTS Serum levels of sST2, IL-33, and pro-inflammation cytokine IL-17 were all up-regulated, while the immunosuppressive cytokine IL-10 was decreased in RA patients. Serum IL-33 level was positively associated with ESR, CRP, and RF, as well as with HAQ score, VAS score, and DAS28 scores (P<0.05). Serum sST2 level was correlated with the morning stiffness time and ESR, as well as scores of HAQ and DAS28 (P<0.05). In addition, IL-33 level was positively corelated with IL-17 (r=0.83, P<0.01) and the relative ratio of IL-10/IL-17 (r=0.904, P<0.01), and was negatively related with IL-10 (r=-0.632, P<0.01). TCM syndrome differentiation was conducted for RA patients, including the hot syndromes and cold syndromes groups. Hot syndromes RA patients had significantly more severe inflammation compared with cold syndromes patients. CONCLUSIONS IL-33 is a possible index for monitoring disease activity and inflammation condition in RA. IL-33 contributes to RA pathogenesis through unbalancing IL-10 and IL-17. In terms of TCM, hot syndromes RA presented more serious inflammation and more active disease activity, indicating a poorer prognosis.

摘要

背景

本研究旨在探讨血清白细胞介素(IL)和可溶性 ST2(sST2)蛋白与类风湿关节炎(RA)患者临床特征和炎症细胞因子的可能相关性,以及中医(TCM)证候区分 RA 患者和评估预后的能力。

材料与方法

纳入 30 例 RA 患者和 25 名健康对照者。评估证候活动度并进行实验室检查。采用 ELISA 法检测血清中 IL-10、IL-17、IL-33 和 sST2 的水平。

结果

RA 患者血清 sST2、IL-33 和促炎细胞因子 IL-17 水平均升高,而免疫抑制细胞因子 IL-10 水平降低。血清 IL-33 水平与 ESR、CRP 和 RF 以及 HAQ 评分、VAS 评分和 DAS28 评分呈正相关(P<0.05)。血清 sST2 水平与晨僵时间和 ESR 以及 HAQ 和 DAS28 评分相关(P<0.05)。此外,IL-33 水平与 IL-17 呈正相关(r=0.83,P<0.01),与 IL-10/IL-17 的比值呈正相关(r=0.904,P<0.01),与 IL-10 呈负相关(r=-0.632,P<0.01)。对 RA 患者进行中医证候分类,包括热证和寒证组。热证 RA 患者的炎症程度明显重于寒证患者。

结论

IL-33 可能是监测 RA 疾病活动度和炎症状态的指标。IL-33 通过失衡 IL-10 和 IL-17 促进 RA 的发病机制。从中医角度来看,热证 RA 患者炎症更严重,疾病活动度更高,预示预后更差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/663b/5996845/c558cf0f0e5b/medscimonit-24-3472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/663b/5996845/e7450742a4ba/medscimonit-24-3472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/663b/5996845/c558cf0f0e5b/medscimonit-24-3472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/663b/5996845/e7450742a4ba/medscimonit-24-3472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/663b/5996845/c558cf0f0e5b/medscimonit-24-3472-g002.jpg

相似文献

1
Prognostic Significance of Serum Interleukins and Soluble ST2 in Traditional Chinese Medicine (TCM) Syndrome-Differentiated Rheumatoid Arthritis.血清白细胞介素和可溶性 ST2 在中医(TCM)辨证类风湿关节炎中的预后意义。
Med Sci Monit. 2018 May 25;24:3472-3478. doi: 10.12659/MSM.907540.
2
Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis.检测类风湿关节炎患者的白细胞介素-33(IL-33)及其受体(sST2 和 ST2L)。
J Korean Med Sci. 2011 Sep;26(9):1132-9. doi: 10.3346/jkms.2011.26.9.1132. Epub 2011 Sep 1.
3
IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.白介素-33 和可溶性 ST2 水平作为早期类风湿关节炎颈动脉斑块消退和进展的新型预测指标:一项前瞻性研究。
Semin Arthritis Rheum. 2015 Aug;45(1):18-27. doi: 10.1016/j.semarthrit.2015.02.001. Epub 2015 Feb 20.
4
Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity.类风湿关节炎患者血清中 IL-35 水平升高与疾病活动度相关。
J Investig Med. 2019 Mar;67(3):707-710. doi: 10.1136/jim-2018-000814. Epub 2019 Jan 18.
5
[Effect of Sanbitang recipe in treatment of rheumatoid arthritis with kidney empty and cold-dampness symptom].三痹汤方治疗肾虚寒湿型类风湿关节炎的疗效
Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(14):2802-2807. doi: 10.19540/j.cnki.cjcmm.20170523.004.
6
Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity.类风湿关节炎患者血清白细胞介素 22 水平升高及其与疾病活动度的相关性。
J Rheumatol. 2012 Jul;39(7):1320-5. doi: 10.3899/jrheum.111027. Epub 2012 May 15.
7
[Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].[类风湿关节炎关节湿热痹阻证患者血清及关节液中白细胞介素-17与血沉、C反应蛋白的相关性研究]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Mar;34(3):272-5.
8
[The objectivity research on 322 rheumatoid arthritis patients of dampness-heat impeding and cold-dampness impeding Chinese medical syndrome types].[322例湿热痹阻与寒湿痹阻中医证型类风湿关节炎患者的客观性研究]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Apr;31(4):466-70.
9
Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis.白细胞介素-32 在类风湿关节炎患者中的表达及其临床意义。
Asian Pac J Allergy Immunol. 2013 Mar;31(1):73-8.
10
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.类风湿关节炎、反应性关节炎和骨关节炎患者血清及滑液中肿瘤坏死因子和白细胞介素-2的可溶性受体
J Rheumatol. 1995 Mar;22(3):406-12.

引用本文的文献

1
A biomarker for bacteremia in pregnant women with acute pyelonephritis: soluble suppressor of tumorigenicity 2 or sST2.急性肾盂肾炎孕妇菌血症的生物标志物:可溶性肿瘤抑制因子 2 或 sST2。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2183470. doi: 10.1080/14767058.2023.2183470.
2
Suppression of Tumorigenicity 2 Pro-Inflammatory Biomarker Linking Diabetes Mellitus and Periodontitis: A Pilot Study.抑瘤素 2 促炎生物标志物与糖尿病和牙周炎的关联:一项初步研究。
Med Sci Monit. 2022 Nov 15;28:e938218. doi: 10.12659/MSM.938218.
3
Efficacy and Safety of Qiwei Tongbi Oral Liquid in Patients with Stable Long-Standing Rheumatoid Arthritis.

本文引用的文献

1
IL-33/ST2-mediated inflammation in macrophages is directly abrogated by IL-10 during rheumatoid arthritis.在类风湿性关节炎期间,白细胞介素-10可直接消除白细胞介素-33/ST2介导的巨噬细胞炎症。
Oncotarget. 2017 May 16;8(20):32407-32418. doi: 10.18632/oncotarget.16299.
2
Foxo4- and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis.颗粒前体蛋白在调节性T细胞中通过Foxo4和Stat3依赖性方式产生白细胞介素-10,从而抑制炎性关节炎。
FASEB J. 2017 Apr;31(4):1354-1367. doi: 10.1096/fj.201601134R. Epub 2016 Dec 23.
3
IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.
芪卫通痹口服液治疗稳定期久痹类风湿关节炎患者的有效性和安全性。
Biomed Res Int. 2021 Oct 23;2021:3930800. doi: 10.1155/2021/3930800. eCollection 2021.
4
IL-33 in Rheumatic Diseases.风湿性疾病中的白细胞介素-33
Front Med (Lausanne). 2021 Sep 13;8:739489. doi: 10.3389/fmed.2021.739489. eCollection 2021.
5
Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.外源性白细胞介素-33 通过重塑肿瘤微环境促进肝癌生长。
J Transl Med. 2020 Dec 11;18(1):477. doi: 10.1186/s12967-020-02661-w.
6
Gyejigachulbutang (Gui-Zhi-Jia-Shu-Fu-Tang, Keishikajutsubuto, TJ-18) in Degenerative Knee Osteoarthritis Patients: Lessons and Responders from a Multicenter Randomized Placebo-Controlled Double-Blind Clinical Trial.桂枝加术附汤(TJ-18)治疗退行性膝关节骨关节炎患者:一项多中心随机安慰剂对照双盲临床试验的经验与有效应答者
Evid Based Complement Alternat Med. 2020 Oct 28;2020:2376581. doi: 10.1155/2020/2376581. eCollection 2020.
白介素-33 和可溶性 ST2 水平作为早期类风湿关节炎颈动脉斑块消退和进展的新型预测指标:一项前瞻性研究。
Semin Arthritis Rheum. 2015 Aug;45(1):18-27. doi: 10.1016/j.semarthrit.2015.02.001. Epub 2015 Feb 20.
4
Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study.中国类风湿关节炎管理中使用的中西医对比:一项随机、单盲、为期24周的研究。
Rheumatol Int. 2014 Dec;34(12):1647-55. doi: 10.1007/s00296-014-3010-6. Epub 2014 Apr 24.
5
Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis.检测类风湿关节炎患者的白细胞介素-33(IL-33)及其受体(sST2 和 ST2L)。
J Korean Med Sci. 2011 Sep;26(9):1132-9. doi: 10.3346/jkms.2011.26.9.1132. Epub 2011 Sep 1.
6
Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.依那西普联合甲氨蝶呤治疗可逆转类风湿关节炎患者的 Th1/Th2、Th17/Treg 失衡。
J Clin Immunol. 2011 Aug;31(4):596-605. doi: 10.1007/s10875-011-9542-6. Epub 2011 May 12.
7
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.2010 年类风湿关节炎分类标准:美国风湿病学会/欧洲抗风湿病联盟合作倡议。
Ann Rheum Dis. 2010 Sep;69(9):1580-8. doi: 10.1136/ard.2010.138461.
8
Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis.血清白细胞介素 33 水平升高与类风湿关节炎患者自身抗体产生有关。
J Rheumatol. 2010 Oct;37(10):2006-13. doi: 10.3899/jrheum.100184. Epub 2010 Aug 3.
9
The assessment of disease activity in rheumatoid arthritis.类风湿关节炎的疾病活动评估。
Clin Exp Rheumatol. 2010 May-Jun;28(3 Suppl 59):S18-27. Epub 2010 Jun 22.
10
Remission in early rheumatoid arthritis.早期类风湿关节炎的缓解。
J Rheumatol. 2010 Jul;37(7):1444-53. doi: 10.3899/jrheum.091131. Epub 2010 Jun 1.